882 related articles for article (PubMed ID: 10957862)
1. Stevens-Johnson syndrome after erythromycin therapy while deployed at sea.
Williams DA
Mil Med; 2000 Aug; 165(8):636-7. PubMed ID: 10957862
[TBL] [Abstract][Full Text] [Related]
2. [Erythema multiforme in children versus Stevens-Johnson syndrome].
Czubkowska I; Barszczak H; Koźniewska D; Wasaznik G
Wiad Lek; 2000; 53(1-2):43-8. PubMed ID: 10806920
[TBL] [Abstract][Full Text] [Related]
3. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme.
Bastuji-Garin S; Rzany B; Stern RS; Shear NH; Naldi L; Roujeau JC
Arch Dermatol; 1993 Jan; 129(1):92-6. PubMed ID: 8420497
[TBL] [Abstract][Full Text] [Related]
4. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
[TBL] [Abstract][Full Text] [Related]
5. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme.
Roujeau JC
J Dermatol; 1997 Nov; 24(11):726-9. PubMed ID: 9433029
[TBL] [Abstract][Full Text] [Related]
6. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome.
Harr T; French LE
Med Clin North Am; 2010 Jul; 94(4):727-42, x. PubMed ID: 20609860
[TBL] [Abstract][Full Text] [Related]
7. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum.
Power WJ; Ghoraishi M; Merayo-Lloves J; Neves RA; Foster CS
Ophthalmology; 1995 Nov; 102(11):1669-76. PubMed ID: 9098260
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome following erythromycin administration.
Lestico MR; Smith AD
Am J Health Syst Pharm; 1995 Aug; 52(16):1805-7. PubMed ID: 8528839
[No Abstract] [Full Text] [Related]
10. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
11. Erythema multiforme, Stevens-Johnson Syndrome, and toxic epidermal necrolysis.
Rasmussen JE
Dermatol Nurs; 1995 Feb; 7(1):37-43. PubMed ID: 7756086
[TBL] [Abstract][Full Text] [Related]
12. Acute blistering diseases on the burn ward: Beyond Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
Richer V; Bouffard D; Bélisle A; Duranceau L; Perreault I; Provost N
Burns; 2013 Sep; 39(6):1290-6. PubMed ID: 23597847
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
[TBL] [Abstract][Full Text] [Related]
14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
[TBL] [Abstract][Full Text] [Related]
15. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
16. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P
Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164
[TBL] [Abstract][Full Text] [Related]
17. Dermatologic emergencies.
Usatine RP; Sandy N
Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
[TBL] [Abstract][Full Text] [Related]
18. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
[TBL] [Abstract][Full Text] [Related]
19. Stevens-Johnson Syndrome: A Challenging Diagnosis.
Davis WD; Schafer PA
Adv Emerg Nurs J; 2018; 40(3):176-182. PubMed ID: 30059372
[TBL] [Abstract][Full Text] [Related]
20. [Stevens-Johnson syndrome due to lymecycline].
Lehembre S; Modeste AB; Joly P
Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):461-3. PubMed ID: 17507845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
